FDA Orange Book · active-ingredient family
Barium sulfate
Barium sulfate is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:E-Z-DISK · NDA 219840
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · for suspension, paste, suspension, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| E-Z-DISKRLD | BRACCO | NDA 219840 | — | Aug 01, 2025 | |
| ENTERO VU 24%RLD×8 | BRACCO | NDA 208143 | — | May 29, 2020 | |
| E-Z-CAT DRYRLD×4 | BRACCO | NDA 208036 | — | Jan 03, 2017 | |
| VARIBAR PUDDING | BRACCO | NDA 208844 | — | Oct 14, 2016 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Barium sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

